2666.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 11:08):

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China...

Stats
Šios dienos apimtis	4.88M
Vidutinė apimtis	4.05M
Rinkos kapitalizacija	8.93B
EPS	HKD0 ( 2023-10-26 )
Last Dividend	HKD0.340 ( 2023-06-09 )
Next Dividend	HKD0 ( N/A )
P/E	4.33
ATR14	HKD0.00200 (0.04%)

Tūris Koreliacija

Ilgas: 0.27 (neutral)

Trumpas: 0.14 (neutral)

Signal:(69.387) Neutral

Genertec Universal Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Genertec Universal Koreliacija - Valiuta/Žaliavos

0.59
( weak )

0.40
( neutral )

0.00
( neutral )

0.80
( moderate )

-0.41
( neutral )

Genertec Universal Finansinės ataskaitos

Annual	2023
Pajamos:	HKD13.65B
Bruto pelnas:	HKD4.57B (33.49 %)
EPS:	HKD1.070

FY	2023
Pajamos:	HKD13.65B
Bruto pelnas:	HKD4.57B (33.49 %)
EPS:	HKD1.070

FY	2022
Pajamos:	HKD11.57B
Bruto pelnas:	HKD4.14B (35.79 %)
EPS:	HKD1.000

FY	2021
Pajamos:	HKD9.91B
Bruto pelnas:	HKD4.20B (42.36 %)
EPS:	HKD0.990

Financial Reports:

No articles found.

Genertec Universal Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.340 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Genertec Universal Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.45 - good (94.51%) | Divividend Growth Potential Score: 5.79 - Stable (15.78%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.130	2016-06-10
Last Dividend	HKD0.340	2023-06-09
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	8	--
Total Paid Out	HKD2.11	--
Avg. Dividend % Per Year	0.00%	--
Score	2.87	--
Div. Sustainability Score	9.45
Div.Growth Potential Score	5.79
Div. Directional Score	7.62	--

Next Divdend (Est)
(2025-03-31)

HKD0.353 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.87

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2327.HK	Ex Dividend Junior	2023-08-03	Sporadic	0.00%
1290.HK	Ex Dividend Junior	2023-06-14	Sporadic	0.00%
0363.HK	Ex Dividend Knight	2023-06-01	Annually	0.00%
6117.HK	Ex Dividend Junior	2023-05-22	Sporadic	0.00%
1857.HK	Ex Dividend Junior	2023-08-23	Semi-Annually	0.00%
0881.HK	Ex Dividend Junior	2023-06-23	Annually	0.00%
0026.HK	Ex Dividend Junior	2023-10-03	Semi-Annually	0.00%
2669.HK	Ex Dividend Knight	2023-06-23	Semi-Annually	0.00%
1428.HK	Ex Dividend Knight	2023-08-23	Annually	0.00%
0518.HK	Ex Dividend Junior	2023-09-01	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.150	1.500	7.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0252	1.200	9.16	10.00	[0 - 0.3]
returnOnEquityTTM	0.118	1.500	9.80	10.00	[0.1 - 1]
payoutRatioTTM	0.293	-1.000	7.07	-7.07	[0 - 1]
currentRatioTTM	1.021	0.800	9.90	7.92	[1 - 3]
quickRatioTTM	0.120	0.800	-4.00	-3.20	[0.8 - 2.5]
cashRatioTTM	0.118	1.500	-0.457	-0.686	[0.2 - 2]
debtRatioTTM	0.649	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	2.45	2.00	9.18	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.01	2.00	8.99	10.00	[0 - 20]
debtEquityRatioTTM	3.01	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.206	1.000	7.88	7.88	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0957	1.000	-0.579	-0.579	[0.2 - 2]
assetTurnoverTTM	0.168	0.800	-2.22	-1.773	[0.5 - 2]
Total Score				9.45

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	4.31	1.000	9.67	0	[1 - 100]
returnOnEquityTTM	0.118	2.50	9.87	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.01	2.00	9.33	10.00	[0 - 30]
dividendYielPercentageTTM	7.95	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.45	2.00	9.18	10.00	[0 - 30]
payoutRatioTTM	0.293	1.500	7.07	-7.07	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.371	1.000	3.23	0	[0.1 - 0.5]
Total Score				5.79

Genertec Universal

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group segment engages in the provision of medical services; hospital and healthcare management; and import and export trading businesses, as well as trading of medical-related goods. The company is also involved in the provision of medical technology; hospital digitalization, construction, and management services; property management; and medical consulting services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.